Next Generation of mRNA Vaccinology: This landscape-changing technology has the potential to be used to manage some of healthcare’s most challenging diseases quickly and efficiently.
Advancements in the generation, purification, and cellular delivery of RNA have enabled the development of mRNA vaccines across a broad array of applications, such as cancer and Zika virus infection. The technology is cost-effective, relatively simple to manufacture, and elicits immunity in a novel way. Furthermore, the emergence of the COVID-19 pandemic demonstrated that the world needed rapid development of a vaccine that was deployable around the globe. Because of previous research that laid the groundwork for this technology, an effective COVID-19 vaccine was developed, produced, approved, and deployed in less than a year. This landscape-changing technology has the potential to be used to manage some of healthcare’s most challenging diseases quickly and efficiently.
Latest from Today's Medical Developments
- Hundreds of leading software solutions for manufacturing converge at IMTS 2024
- Upcoming webinar to highlight the rise of electric vehicles
- Four US automation companies unite under one brand—HAHN Automation Group US
- Okuma America Corporation's comprehensive IMTS lineup
- IMTS 2024 Conference: Precision Repeatability: How To Make Great Parts Over and Over and Over Again
- Cretex Medical announces plans for Costa Rica facility
- Starrett touchscreen wireless digital indicator
- IMTS 2024 Conference: How Their First Robot Purchase Enabled a 70-year Old Company with 11 Facilities on 3 Continents to Profitably Expand their Domestic Manufacturing
